Tizanidine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43063-868 -
Package NDC
43063-868-12 -
Package NDC
43063-868-30 -
Package NDC
43063-868-60 -
Application number
ANDA091283 -
SPL ID
601ba105-1e7a-3893-e063-6294a90af0ca -
SPL set ID
615dfd5c-125a-40e2-a6da-afacde305282 -
UNII
B53E3NMY5C -
RxCUI
313412
What the source publishes
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Active ingredients
- Tizanidine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tizanidine",
"splId": "601ba105-1e7a-3893-e063-6294a90af0ca",
"labels": [
{
"setId": "615dfd5c-125a-40e2-a6da-afacde305282",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=615dfd5c-125a-40e2-a6da-afacde305282",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=615dfd5c-125a-40e2-a6da-afacde305282"
}
],
"routes": [
"ORAL"
],
"labeler": "PD-Rx Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "12 TABLET in 1 BOTTLE, PLASTIC (43063-868-12)",
"package_ndc": "43063-868-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20180709"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-868-30)",
"package_ndc": "43063-868-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20180709"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE, PLASTIC (43063-868-60)",
"package_ndc": "43063-868-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20180709"
}
],
"productId": "43063-868_601ba105-1e7a-3893-e063-6294a90af0ca",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "43063-868",
"deaSchedule": null,
"genericName": "Tizanidine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TIZANIDINE HYDROCHLORIDE",
"strength": "2 mg/1"
}
],
"applicationNumber": "ANDA091283",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20130401",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0343063868607"
],
"unii": [
"B53E3NMY5C"
],
"rxcui": [
"313412"
],
"spl_set_id": [
"615dfd5c-125a-40e2-a6da-afacde305282"
],
"manufacturer_name": [
"PD-Rx Pharmaceuticals, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43063-868_601ba105-1e7a-3893-e063-6294a90af0ca"